Kllotas (Dutasteride, Tamsulosin Chloride)

Dutasteride blocks both type I and type II 5‑alpha‑reductase enzymes, lowering the conversion of testosterone to dihydrotestosterone, which reduces prostate growth. Tamsulosin selectively antagonizes α1A‑adrenergic receptors in the prostate and bladder neck, causing smooth‑muscle relaxation. Together they address hormonal enlargement and dynamic obstruction that cause BPH symptoms.

The dosage of Kllotas is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and concomitant therapies. Physicians typically follow established guidelines for dutasteride and tamsulosin, but the exact strength and frequency should only be set by a qualified healthcare professional.

Kllotas is not indicated for use in women, including those who are pregnant or breastfeeding. Dutasteride can affect fetal development, and tamsulosin has not been studied in these populations. Women of child‑bearing potential should avoid handling the medication and should discuss any exposure concerns with a healthcare provider.

To order Kllotas, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements if applicable) and the necessary import documentation.

Kllotas combines two mechanisms—hormonal suppression (dutasteride) and smooth‑muscle relaxation (tamsulosin)—offering a broader therapeutic effect than monotherapy with either agent alone. Compared with finasteride, dutasteride provides more complete 5‑alpha‑reductase inhibition. Compared with tamsulosin alone, the combination also reduces prostate size, potentially decreasing the need for surgical intervention.

Kllotas tablets should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Kllotas is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water. Patients should follow any specific instructions regarding timing relative to other medications to minimize interaction risk.

Serious adverse events include orthostatic hypotension, which can cause fainting; priapism, a prolonged painful erection requiring emergency care; and severe allergic reactions such as rash, swelling or breathing difficulty. Patients should seek immediate medical attention if any of these symptoms occur.

Kllotas should not be used by women, children, or anyone with a known hypersensitivity to dutasteride, tamsulosin, or any tablet excipients. Patients with severe liver impairment, uncontrolled hypotension, or a history of priapism should also avoid this medication unless a physician determines that benefits outweigh risks.